摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(2-aminoethyl)(methyl)amino]pyridine | 796038-28-3

中文名称
——
中文别名
——
英文名称
4-[(2-aminoethyl)(methyl)amino]pyridine
英文别名
N-methyl-N-4-pyridinyl-1,2-ethanediamine;N1-methyl-N1-pyridin-4-yl-ethane-1,2-diamine;N1-Methyl-N1-pyridin-4-yl-ethane-1,2-diamine;N'-methyl-N'-pyridin-4-ylethane-1,2-diamine
4-[(2-aminoethyl)(methyl)amino]pyridine化学式
CAS
796038-28-3
化学式
C8H13N3
mdl
——
分子量
151.211
InChiKey
LUCZJSWUOIAORJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    271.8±20.0 °C(Predicted)
  • 密度:
    1.073±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    42.2
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-[(2-aminoethyl)(methyl)amino]pyridine 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 反应 6.5h, 生成 N-(3,5-bis{[2-(methyl[pyridin-4-yl]amino)ethylamino]methyl}benzyl)-N'-methyl-N'-pyridin-4-ylethane-1,2-diamine
    参考文献:
    名称:
    Effects of Polymer Architecture and Nanoenvironment in Acylation Reactions Employing Dendritic (Dialkylamino)pyridine Catalysts
    摘要:
    The role of architecture and nanoenvironment in the catalytic properties of dendritic polymers containing 4-(dialkylamino)pyridines was investigated in the context of acylation reactions employing sterically demanding tertiary alcohols as substrates. Frechet-type benzyl ether and aliphatic ester dendrimers were prepared in a convergent manner from a common trivalent core containing three DMAP groups while a linear polymer was dendronized with aliphatic esters using a divergent growth scheme. Catalysis experiments clearly indicate that nanoenvironment plays the dominant role in determining the activity of the polymer catalysts, with the polyester platform being superior to the benzyl ether. Polymer architecture played little or no role in affecting catalysis. With respect to molecular transport and catalysis, this represents the first comparative study of the effect of architecture and nanoenvironment using structurally similar dendritic materials.
    DOI:
    10.1021/ma050701m
  • 作为产物:
    参考文献:
    名称:
    多金属氧酸盐基有机催化剂中的分子内阴离子效应:金属氧化物与有机阳离子相互作用的反应性增强和手性转移
    摘要:
    的α 1 -Dawson聚阴离子轴承用4-氨基吡啶端基的横向侧链的合成。这种有机多金属氧酸盐催化将茚基烯丙基硅烷加到肉桂酰氟上。聚阴离子骨架影响有机催化剂的活性和选择性。观察到从手性无机骨架到有机底物的适度但非零的手性转移。
    DOI:
    10.1002/chem.201403989
点击查看最新优质反应信息

文献信息

  • Shell Cross‐Linked Micelles as Nanoreactors for Enantioselective Three‐Step Tandem Catalysis
    作者:Michael Kuepfert、Aaron E. Cohen、Olivia Cullen、Marcus Weck
    DOI:10.1002/chem.201804956
    日期:2018.12.12
    enantio‐enriched alcohols in the crosslinked shell, and nucleophilic base‐catalyzed acylation in the hydrophobic core. The catalysts are positioned in close proximity on a single micelle support to take advantage of the intramicellar substrate diffusion, yet they are sufficiently spaced apart from each other in physically distinct microenvironments. These compartmentalized micelles are substrate selective
    描述了组装成壳交联胶束(SCM)的功能化两亲性聚(2-恶唑啉)基三嵌段共聚物。这些胶束可通过分隔将三种不相容的催化剂进行位点分离,从而在一锅中实现三步非正交串联工艺。尤其是,在亲水性电晕中酸催化的缩酮水解为前手性酮,然后在交联壳中进行Rh催化的不对称转移氢化为对映体富集的醇,并在疏水核中进行了亲核碱催化的酰化反应。将催化剂紧密地放置在单个胶束载体上,以利用胶束内底物扩散的优势,但它们在物理上不同的微环境中彼此充分隔开。
  • [EN] 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES<br/>[FR] DERIVES AMIDES DE L'ACIDE CARBOXYLIQUE DE 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE 3 ET COMPOSES ASSOCIES EN TANT QU'ANTAGONISTES DE RECEPTEUR DE B1 DE LA BRADYKININE POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES
    申请人:ELAN PHARM INC
    公开号:WO2004098589A1
    公开(公告)日:2004-11-18
    Disclosed are compounds of formula I and II that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.
    公开的是化合物I和II的结构式,它们是激肽酶B1受体拮抗剂,适用于治疗哺乳动物中由激肽酶B1受体介导的疾病,或缓解与疾病状况相关的不良症状。其中某些化合物表现出增强的效力,并且预计还将表现出延长作用的特性。
  • Bis (amino acid) molecular scaffolds
    申请人:——
    公开号:US20040077879A1
    公开(公告)日:2004-04-22
    The present invention provides molecular building blocks of rigid bis(amino acids). The molecular building blocks can be linked together through the formation of rigid diketopiperazine rings, to provide the desired three dimensional structure. Also provided is method of synthesizing macromolecules from the bis (amino acid) building blocks.
    本发明提供了刚性双(氨基酸)的分子构建模块。这些分子构建模块可以通过形成刚性二酮二肽环相互连接,以提供所需的三维结构。同时提供了一种从双(氨基酸)构建模块合成高分子的方法。
  • Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
    申请人:Tung S. Jay
    公开号:US20050020659A1
    公开(公告)日:2005-01-27
    Disclosed are compounds that are bradykinin B 1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B 1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.
    本发明公开了一种布雷肯肽B1受体拮抗剂化合物,可用于治疗哺乳动物中由布雷肯肽B1受体介导的疾病或缓解与疾病状况相关的不良症状。其中某些化合物表现出增强的效力,并且预计也会表现出增强的作用持续时间。
  • 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carvoxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
    申请人:Tung S. Jay
    公开号:US20060281733A1
    公开(公告)日:2006-12-14
    Disclosed are compounds of formula I and II that are bradykinin B 1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B 1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.
    本发明公开了式I和式II的化合物,它们是缓激肽B1受体拮抗剂,可用于治疗哺乳动物中由缓激肽B1受体介导的疾病,或缓解与疾病条件相关的不良症状。其中某些化合物表现出增强的效力,预计也会表现出增强的持续时间。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰